- Home
- MRNA vs ELS Comparison
MRNA vs ELS Comparison
Compare MRNA & ELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | ELS |
|---|---|---|
| Founded | 2010 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 13.2B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MRNA | ELS |
|---|---|---|
| Price | $55.54 | $67.85 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 9 |
| Target Price | $33.00 | ★ $70.72 |
| AVG Volume (30 Days) | ★ 9.6M | 1.6M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.22% |
| EPS Growth | ★ 21.77 | 2.55 |
| EPS | N/A | ★ 2.01 |
| Revenue | ★ $19,263,000,000.00 | $1,531,382,000.00 |
| Revenue This Year | $8.28 | $3.52 |
| Revenue Next Year | $16.53 | $4.27 |
| P/E Ratio | ★ N/A | $33.51 |
| Revenue Growth | ★ 4.29 | 0.34 |
| 52 Week Low | $22.28 | $57.63 |
| 52 Week High | $59.55 | $69.28 |
Technical Indicators
Market Signals| Indicator | MRNA | ELS |
|---|---|---|
| Relative Strength Index (RSI) | 63.68 | 59.74 |
| Support Level | $23.74 | $61.11 |
| Resistance Level | N/A | $68.54 |
| Average True Range (ATR) | 3.84 | 1.07 |
| MACD | 0.26 | -0.20 |
| Stochastic Oscillator | 69.97 | 58.06 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About ELS Equity Lifestyle Properties Inc.
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the US with a higher concentration in the Sunbelt; 38% of the company's properties are in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations. More than 70% of the company's properties are either age-restricted or have an average resident age over 55.